| Payam Marouni Md Inc. | |
|
8338 Rosemead Blvd Pico Rivera CA 90660-5111 | |
| (562) 942-1200 | |
| (562) 942-1200 |
| Full Name | Payam Marouni Md Inc. |
|---|---|
| Speciality | Family Medicine |
| Location | 8338 Rosemead Blvd, Pico Rivera, California |
| Authorized Official Name and Position | Payam Marouni (MD) |
| Authorized Official Contact | 8189889090 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Payam Marouni Md Inc. Po Box 19211 Encino CA 91416-9211 Ph: (818) 988-9090 | Payam Marouni Md Inc. 8338 Rosemead Blvd Pico Rivera CA 90660-5111 Ph: (562) 942-1200 |
| NPI Number | 1114255437 |
|---|---|
| Provider Enumeration Date | 11/24/2009 |
| Last Update Date | 11/28/2022 |
| Medicare PECOS PAC ID | 8527100775 |
|---|---|
| Medicare Enrollment ID | O20100126000561 |
News Archive
A possible diagnostic use for clot-dissolving drugs such as tPA has been found by Medical College of Georgia researchers working to improve a test that identifies potentially deadly blood clots in the legs.
Almost a century after it was discovered in fruit flies with notches in their wings, the Notch signalling pathway may come to play an important role in the recovery from heart attacks. In a study published today in Circulation Research, scientists at the European Molecular Biology Laboratory (EMBL) in Monterotondo, Italy, are the first to prove that this signalling pathway targets heart muscle cells and thus reveal its crucial role in heart development and repair
Delcath Systems, Inc., announced today that the first patients in Germany have been treated with the Delcath Hepatic CHEMOSAT Delivery System at the Johann Wolfgang Goethe University Hospital, a premier European cancer treatment and research center located in Frankfurt. The cases were treated as part of the initial launch and training agreement the Company announced with the hospital in December 2011.
Two of the most prestigious names in Southern California health care - Cedars-Sinai and UCLA - are getting shut out of a major insurance plan for being too expensive. In a bold cost-cutting move, Anthem Blue Cross has eliminated doctors affiliated with the hospitals from a health plan offered to about 60,000 employees and dependents at the cash-strapped city of Los Angeles.
Progenics Pharmaceuticals, Inc. and Salix Pharmaceuticals, Ltd. today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing a supplemental New Drug Application (sNDA) for RELISTOR Subcutaneous Injection to treat opioid-induced constipation (OIC) in patients with non-cancer pain.
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114255437 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (California) | Primary |
| Provider Name | Payam Marouni |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1386800225 PECOS PAC ID: 9830241751 Enrollment ID: I20090723000263 |
News Archive
A possible diagnostic use for clot-dissolving drugs such as tPA has been found by Medical College of Georgia researchers working to improve a test that identifies potentially deadly blood clots in the legs.
Almost a century after it was discovered in fruit flies with notches in their wings, the Notch signalling pathway may come to play an important role in the recovery from heart attacks. In a study published today in Circulation Research, scientists at the European Molecular Biology Laboratory (EMBL) in Monterotondo, Italy, are the first to prove that this signalling pathway targets heart muscle cells and thus reveal its crucial role in heart development and repair
Delcath Systems, Inc., announced today that the first patients in Germany have been treated with the Delcath Hepatic CHEMOSAT Delivery System at the Johann Wolfgang Goethe University Hospital, a premier European cancer treatment and research center located in Frankfurt. The cases were treated as part of the initial launch and training agreement the Company announced with the hospital in December 2011.
Two of the most prestigious names in Southern California health care - Cedars-Sinai and UCLA - are getting shut out of a major insurance plan for being too expensive. In a bold cost-cutting move, Anthem Blue Cross has eliminated doctors affiliated with the hospitals from a health plan offered to about 60,000 employees and dependents at the cash-strapped city of Los Angeles.
Progenics Pharmaceuticals, Inc. and Salix Pharmaceuticals, Ltd. today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing a supplemental New Drug Application (sNDA) for RELISTOR Subcutaneous Injection to treat opioid-induced constipation (OIC) in patients with non-cancer pain.
› Verified 5 days ago
News Archive
A possible diagnostic use for clot-dissolving drugs such as tPA has been found by Medical College of Georgia researchers working to improve a test that identifies potentially deadly blood clots in the legs.
Almost a century after it was discovered in fruit flies with notches in their wings, the Notch signalling pathway may come to play an important role in the recovery from heart attacks. In a study published today in Circulation Research, scientists at the European Molecular Biology Laboratory (EMBL) in Monterotondo, Italy, are the first to prove that this signalling pathway targets heart muscle cells and thus reveal its crucial role in heart development and repair
Delcath Systems, Inc., announced today that the first patients in Germany have been treated with the Delcath Hepatic CHEMOSAT Delivery System at the Johann Wolfgang Goethe University Hospital, a premier European cancer treatment and research center located in Frankfurt. The cases were treated as part of the initial launch and training agreement the Company announced with the hospital in December 2011.
Two of the most prestigious names in Southern California health care - Cedars-Sinai and UCLA - are getting shut out of a major insurance plan for being too expensive. In a bold cost-cutting move, Anthem Blue Cross has eliminated doctors affiliated with the hospitals from a health plan offered to about 60,000 employees and dependents at the cash-strapped city of Los Angeles.
Progenics Pharmaceuticals, Inc. and Salix Pharmaceuticals, Ltd. today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing a supplemental New Drug Application (sNDA) for RELISTOR Subcutaneous Injection to treat opioid-induced constipation (OIC) in patients with non-cancer pain.
› Verified 5 days ago
Beverlycare Pico Rivera Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 8862 Whittier Blvd, Pico Rivera, CA 90660 Phone: 323-725-5073 | |
Friends Of Family Health Center Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 5062 Rosemead Blvd, Pico Rivera, CA 90660 Phone: 562-801-2287 Fax: 562-690-3182 | |
Eldorado Community Service Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 8207 Whittier Blvd, Pico Rivera, CA 90660 Phone: 562-692-2522 Fax: 562-695-0413 | |
Gemma Th Ko,md. Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 4511 Rosemead Blvd, Pico Rivera, CA 90660 Phone: 562-692-3388 | |
San Martin De Porres Medical Center Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 9315 Telegraph Rd, Pico Rivera, CA 90660 Phone: 562-654-6855 | |
San Martin De Porres Medical Clinic Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 9315 Telegraph Rd, Pico Rivera, CA 90660 Phone: 562-654-6855 Fax: 562-654-6856 |